Hemophilia A and B are similar conditions that affect the blood’s ability to clot. They typically occur due to gene variations that affect different blood clotting factors. Hemophilia is a group of ...

Blood clots can form in both arteries and veins. However, the reasons behind them differ, as do the consequences and the chances of preventing blood clots. In Sweden, almost half of all cases of ...

Research by RCSI University of Medicine and Health Sciences has discovered a new role for the blood clotting protein, von Willebrand Factor (VWF), that could lead to the development of new treatments ...

All that most laymen know about hemophilia is that it is an odd and dangerous disease of the blood that strikes men only, although it is transmitted by women. Medical researchers have learned a great ...

A blood clot is a potential complication after surgery. To help prevent blood clots, a doctor may advise doing exercises to promote blood flow, wearing compression garments, and taking blood-thinning ...

Few bodily functions are as misunderstood as blood clots. While most people have heard about blood clots in the heart or brain causing serious issues or even death, fewer realize that blood clotting ...

Genetic research in Sweden has unveiled three new gene variants that dramatically increase the risk of venous blood clots, sometimes by up to 180%. These discoveries build on existing knowledge of ...

Hemophilia may lead to internal bleeding, particularly in joints and the brain, which could cause pain, swelling, and neurological symptoms. Preventive treatment with clotting factor concentrates and ...

Blood clotting disorders can be inherited or acquired and lead to either excessive bleeding or too much clotting. Hypercoagulable disorders can cause dangerous blockages due to excessive blood ...

(NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization to expand the approved indication for HYMPAVZI ® (marstacimab) to include patients 12 years of age and ...